These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 30963549)

  • 1. Novel approaches for the design, delivery and administration of vaccine technologies.
    Wallis J; Shenton DP; Carlisle RC
    Clin Exp Immunol; 2019 May; 196(2):189-204. PubMed ID: 30963549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of antigens used for vaccination: recent advances and challenges.
    Scherliess R
    Ther Deliv; 2011 Oct; 2(10):1351-68. PubMed ID: 22826888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontiers of transcutaneous vaccination systems: novel technologies and devices for vaccine delivery.
    Matsuo K; Hirobe S; Okada N; Nakagawa S
    Vaccine; 2013 May; 31(19):2403-15. PubMed ID: 23523401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in veterinary vaccine adjuvants.
    Singh M; O'Hagan DT
    Int J Parasitol; 2003 May; 33(5-6):469-78. PubMed ID: 12782048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines?
    Bobbala S; Hook S
    Pharm Res; 2016 Sep; 33(9):2078-97. PubMed ID: 27380191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial.
    Bernstein DI; Guptill J; Naficy A; Nachbagauer R; Berlanda-Scorza F; Feser J; Wilson PC; Solórzano A; Van der Wielen M; Walter EB; Albrecht RA; Buschle KN; Chen YQ; Claeys C; Dickey M; Dugan HL; Ermler ME; Freeman D; Gao M; Gast C; Guthmiller JJ; Hai R; Henry C; Lan LY; McNeal M; Palm AE; Shaw DG; Stamper CT; Sun W; Sutton V; Tepora ME; Wahid R; Wenzel H; Wohlbold TJ; Innis BL; García-Sastre A; Palese P; Krammer F
    Lancet Infect Dis; 2020 Jan; 20(1):80-91. PubMed ID: 31630990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fundamentals of Fish Vaccination.
    Bedekar MK; Kole S
    Methods Mol Biol; 2022; 2411():147-173. PubMed ID: 34816404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of new vaccine technologies for the control of transboundary diseases.
    Swayne DE
    Dev Biol (Basel); 2004; 119():219-28. PubMed ID: 15742632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Needle-free vaccine delivery.
    Giudice EL; Campbell JD
    Adv Drug Deliv Rev; 2006 Apr; 58(1):68-89. PubMed ID: 16564111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined adjuvant-delivery system for new generation vaccine antigens: alliance has its own advantage.
    Kaurav M; Madan J; Sudheesh MS; Pandey RS
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S818-S831. PubMed ID: 30307332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvants and delivery issues related to immunization: a survey of the recent patent literature.
    Mrsny RJ
    J Drug Target; 1998; 6(4):243-9. PubMed ID: 9894692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Order of Live and Inactivated Vaccines and Risk of Non-vaccine-targeted Infections in US Children 11-23 Months of Age.
    Newcomer SR; Daley MF; Narwaney KJ; Xu S; DeStefano F; Groom HC; Jackson ML; Lewin BJ; McLean HQ; Nordin JD; Zerbo O; Glanz JM
    Pediatr Infect Dis J; 2020 Mar; 39(3):247-253. PubMed ID: 32032310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of interleukin 12 to enhance the cellular immune response of swine to an inactivated herpesvirus vaccine.
    Zuckermann FA; Martin S; Husmann RJ; Brandt J
    Adv Vet Med; 1999; 41():447-61. PubMed ID: 9890035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an Alternative Modified Live Influenza B Virus Vaccine.
    Santos JJS; Finch C; Sutton T; Obadan A; Aguirre I; Wan Z; Lopez D; Geiger G; Gonzalez-Reiche AS; Ferreri L; Perez DR
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28381580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus-like particles for antigen delivery at mucosal surfaces.
    Schneider-Ohrum K; Ross TM
    Curr Top Microbiol Immunol; 2012; 354():53-73. PubMed ID: 21744306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model.
    Liu WC; Nachbagauer R; Stadlbauer D; Solórzano A; Berlanda-Scorza F; García-Sastre A; Palese P; Krammer F; Albrecht RA
    Front Immunol; 2019; 10():756. PubMed ID: 31105689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seasonal influenza vaccines.
    Fiore AE; Bridges CB; Cox NJ
    Curr Top Microbiol Immunol; 2009; 333():43-82. PubMed ID: 19768400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview and Future Potential of Fast Dissolving Buccal Films as Drug Delivery System for Vaccines.
    Uddin MN; Allon A; Roni MA; Kouzi S
    J Pharm Pharm Sci; 2019; 22(1):388-406. PubMed ID: 31386612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Considerations for development of whole cell bacterial vaccines to prevent diarrheal diseases in children in developing countries.
    Walker RI
    Vaccine; 2005 May; 23(26):3369-85. PubMed ID: 15837361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.